Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on September 23, 2026

10 hours ago

AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104

Indeterminate GlobeNewswire

10 hours ago

Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress

Indeterminate GlobeNewswire

10 hours ago

Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum

Indeterminate GlobeNewswire

10 hours ago

Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing

Indeterminate GlobeNewswire

10 hours ago

Verano to Report Third Quarter 2026 Financial Results on October 29, 2026

Indeterminate GlobeNewswire

10 hours ago

Psyence BioMed Announces Strategic Ibogaine Investment

Indeterminate GlobeNewswire

10 hours ago

Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus

Indeterminate GlobeNewswire

10 hours ago

Grey Matters Announces the Closing of its Equity and Convertible Debenture Private Placement totalling CAD $1.12 Million

Indeterminate GlobeNewswire

10 hours ago

Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026

Indeterminate GlobeNewswire

10 hours ago

Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus

Indeterminate GlobeNewswire

10 hours ago

ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension

Indeterminate GlobeNewswire

11 hours ago

Rabies in Cape Fur Seals: What New South African Research Could Mean for Canada

Indeterminate GlobeNewswire

11 hours ago

La rage chez les otaries à fourrure du Cap : ce que les nouvelles recherches sud-africaines pourraient signifier pour le Canada

Indeterminate GlobeNewswire

12 hours ago

Lift Therapeutics Appoints Daniel Passeri as Chief Executive Officer

Indeterminate GlobeNewswire

12 hours ago

ITM and Lumara Bio Announce Upcoming Dosimetry and Re-treatment Data Presentations on ¹⁷⁷Lu-edotreotide at ASTRO 2026

Indeterminate GlobeNewswire

12 hours ago

Suppléments sportifs : mieux informer la population face à un phénomène en expansion

Indeterminate GlobeNewswire

13 hours ago

Engitix appoints Sonia Quaratino, MD, PhD as EVP Chief Medical Officer as its ECM pipeline moves toward clinical development

Indeterminate GlobeNewswire

13 hours ago

Actimed Therapeutics Completes Recruitment for PROACT Phase 2a Study Evaluating S-pindolol benzoate (ACM 001.1) in Obese Adults During and After Semaglutide Therapy

Indeterminate GlobeNewswire

13 hours ago

Boehringer Ingelheim and AWARE launch new Stop Rabies project in Zimbabwe to help protect dogs and communities

Indeterminate GlobeNewswire

13 hours ago

Scarlet Therapeutics Secures DARPA Agreement to Develop Adaptive Smart Red Blood Cells

Indeterminate GlobeNewswire